A. Jason Keyes's Insider Trades & SAST Disclosures
A. Jason Keyes's most recent trade in Equillium Inc was a trade of 175,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern A. Jason Keyes.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 175,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 125,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 100,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 90,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 90,000 | 90,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 70,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 70,000 | 70,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 23 Jan 2025 | 10,000 | 37,720 (0%) | 0% | 0.7 | 6,500 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.54 per share. | 02 Jan 2025 | 15,000 | 88,913 (0%) | 0% | 0.5 | 8,100 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.70 per share. | 14 Nov 2024 | 10,000 | 47,720 (0%) | 0% | 0.7 | 7,000 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.81 per share. | 26 Sep 2024 | 10,000 | 57,720 (0%) | 0% | 0.8 | 8,100 | Common Stock |
| Actuate Therapeutics Inc. | Jason A. Keyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 30,000 | 30,000 | - | - | Non-Qualified Stock Options | |
| Equillium Inc | A. Keyes Jason | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.87 per share. | 16 Jul 2024 | 10,000 | 67,720 (0%) | 0% | 0.9 | 8,700 | Common Stock |
| Equillium Inc | A. Jason Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.56 per share. | 02 Jan 2024 | 15,000 | 50,108 (0%) | 0% | 0.6 | 8,400 | Common Stock |
| Equillium Inc | A. Keyes Jason | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.58 per share. | 02 Jan 2024 | 8,805 | 58,913 (0%) | 0% | 0.6 | 5,107 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.19 per share. | 03 Jan 2023 | 4,444 | 35,108 (0%) | 0% | 1.2 | 5,288 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.83 per share. | 29 Aug 2022 | 7,000 | 77,720 (0%) | 0% | 2.8 | 19,810 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 06 Jun 2022 | 5,000 | 84,720 (0%) | 0% | 2.5 | 12,600 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.18 per share. | 04 Apr 2022 | 8,000 | 89,720 (0%) | 0% | 3.2 | 25,440 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 2.35 per share. | 10 Dec 2021 | 5,585 | 23,296 (0%) | 0% | 2.4 | 13,125 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 01 Dec 2021 | 5,000 | 97,720 (0%) | 0% | 5.1 | 25,402 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 27 Sep 2021 | 8,000 | 102,720 (0%) | 0% | 6.7 | 53,924 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.72 per share. | 27 Jul 2021 | 5,000 | 110,720 (0%) | 0% | 5.7 | 28,585 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 2.35 per share. | 10 Jun 2021 | 5,535 | 17,711 (0%) | 0% | 2.3 | 13,007 | Common stock, par value $0.0001 per share |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 26 May 2021 | 5,000 | 115,720 (0%) | 0% | 6.5 | 32,484 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.74 per share. | 23 Dec 2020 | 8,000 | 120,720 (0%) | 0% | 4.7 | 37,914 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Other type of transaction at price $ 2.35 per share. | 10 Dec 2020 | 5,362 | 12,176 (0%) | 0% | 2.4 | 12,601 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Other type of transaction at price $ 2.41 per share. | 10 Jun 2020 | 5,014 | 6,814 (0%) | 0% | 2.4 | 12,084 | Common Stock |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2020 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Apr 2020 | 90,000 | 0 | - | - | Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2020 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Equillium Inc | Jason A. Keyes | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Apr 2020 | 70,000 | 0 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges